SCN4A Gene

HGNC Family Ion channels
Name sodium channel, voltage gated, type IV alpha subunit
Description Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. It is expressed in skeletal muscle, and mutations in this gene have been linked to several myotonia and periodic paralysis disorders. [provided by RefSeq, Jul 2008]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nSCN4A encodes the pore‐forming α‐subunit of the skeletal muscle voltage‐gated sodium channel (NaV1.4), which is essential for initiating and propagating action potentials in muscle fibers. Recent structural analyses using cryo–electron microscopy have revealed the detailed architecture of the NaV1.4 channel complex—including the pore region and voltage–sensing domains—and have provided insight into the molecular basis of ion permeation and the allosteric mechanisms that govern fast inactivation. In addition, regulatory factors such as calmodulin binding and membrane sialylation have been shown to modulate channel gating and surface expression, thereby fine–tuning muscle excitability."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMutations in SCN4A disturb the precise control of channel activation and inactivation, thereby leading to a wide spectrum of skeletal muscle channelopathies. Gain–of–function mutations can enhance aberrant sodium currents—such as resurgent or window currents—resulting in hyperexcitability that underlies non–dystrophic myotonias, paramyotonia congenita, and periodic paralysis, often with features such as cold sensitivity, episodic weakness, laryngospasm, or even essential tremor. Conversely, loss–of–function mutations may reduce channel availability to an extent that compromises action potential amplitude and manifests as congenital myopathy or myasthenic syndromes with early–onset weakness. Detailed biophysical and pharmacological studies in heterologous systems have demonstrated that these SCN4A mutations alter the balance between activation and inactivation kinetics, shift voltage–dependencies, and in some cases create abnormal gating pore currents. Moreover, modulation of channel function by pharmacological agents including ranolazine, mexiletine, flecainide, and cannabidiol has been explored as potential targeted treatments to restore normal excitability. Collectively, these findings, corroborated by genetic screening and in vivo experimental models, highlight the critical role of SCN4A in maintaining skeletal muscle function and emphasize that the phenotypic variability of SCN4A–related disorders reflects both the nature of specific mutations and their impact on sodium channel biophysics."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "49"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Xiaojing Pan, Zhangqiang Li, Qiang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structure of the human voltage-gated sodium channel Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "v"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.4 in complex with β1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aau2486"}], "href": "https://doi.org/10.1126/science.aau2486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30190309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30190309"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Subrata Biswas, Isabelle Deschênes, Deborah Disilvestre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calmodulin regulation of Nav1.4 current: role of binding to the carboxyl terminus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Physiol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1085/jgp.200709863"}], "href": "https://doi.org/10.1085/jgp.200709863"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18270170"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18270170"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jesse B Yoder, Manu Ben-Johny, Federica Farinelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ca"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "2+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-dependent regulation of sodium channels Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.4 and Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.5 is controlled by the post-IQ motif."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-019-09570-7"}], "href": "https://doi.org/10.1038/s41467-019-09570-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30944319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30944319"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Rong Chen, Shin-Ho Chung "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of tetrodotoxin block and resistance in sodium channels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.02.115"}], "href": "https://doi.org/10.1016/j.bbrc.2014.02.115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24607901"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24607901"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jörg Ahrens, Nilufar Foadi, Ania Eberhardt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defective polysialylation and sialylation induce opposite effects on gating of the skeletal Na+ channel NaV1.4 in Chinese hamster ovary cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000327389"}], "href": "https://doi.org/10.1159/000327389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21606664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21606664"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Akira Tsujino, Chantal Maertens, Kinji Ohno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myasthenic syndrome caused by mutation of the SCN4A sodium channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1230273100"}], "href": "https://doi.org/10.1073/pnas.1230273100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12766226"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12766226"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "E Matthews, R Labrum, M G Sweeney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000342387.65477.46"}], "href": "https://doi.org/10.1212/01.wnl.0000342387.65477.46"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19118277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19118277"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Brian W Jarecki, Andrew D Piekarz, James O Jackson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI40801"}], "href": "https://doi.org/10.1172/JCI40801"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20038812"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20038812"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Irina T Zaharieva, Michael G Thor, Emily C Oates, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awv352"}], "href": "https://doi.org/10.1093/brain/awv352"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26700687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26700687"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jaya R Trivedi, Brian Bundy, Jeffrey Statland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non-dystrophic myotonia: prospective study of objective and patient reported outcomes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awt133"}], "href": "https://doi.org/10.1093/brain/awt133"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23771340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23771340"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "J Trip, G Drost, H B Ginjaar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Redefining the clinical phenotypes of non-dystrophic myotonic syndromes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurol Neurosurg Psychiatry (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jnnp.2008.162396"}], "href": "https://doi.org/10.1136/jnnp.2008.162396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19211598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19211598"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "L Lion-Francois, C Mignot, S Vicart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3181ed9e96"}], "href": "https://doi.org/10.1212/WNL.0b013e3181ed9e96"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20713951"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20713951"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "S Vicart, D Sternberg, E Fournier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000145768.09934.ec"}], "href": "https://doi.org/10.1212/01.wnl.0000145768.09934.ec"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15596759"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15596759"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jeroen Trip, Gea Drost, Dennis J Verbove, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2008.39"}], "href": "https://doi.org/10.1038/ejhg.2008.39"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18337730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18337730"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Roope Männikkö, Leonie Wong, David J Tester, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysfunction of NaV1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(18)30021-7"}], "href": "https://doi.org/10.1016/S0140-6736(18"}, {"type": "t", "text": "30021-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29605429"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29605429"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "W David Arnold, Daniel H Feldman, Sandra Ramirez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.24389"}], "href": "https://doi.org/10.1002/ana.24389"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25707578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25707578"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "James R Groome, Frank Lehmann-Horn, Chunxiang Fan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NaV1.4 mutations cause hypokalaemic periodic paralysis by disrupting IIIS4 movement during recovery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awu015"}], "href": "https://doi.org/10.1093/brain/awu015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24549961"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24549961"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "E Matthews, S V Tan, D Fialho, et al. "}, {"type": "b", "children": [{"type": "t", "text": "What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000287069.21162.94"}], "href": "https://doi.org/10.1212/01.wnl.0000287069.21162.94"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18166706"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18166706"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Daohua Jiang, Tamer M Gamal El-Din, Christopher Ing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis for gating pore current in periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41586-018-0120-4"}], "href": "https://doi.org/10.1038/s41586-018-0120-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29769724"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29769724"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jadon Webb, Stephen C Cannon "}, {"type": "b", "children": [{"type": "t", "text": "Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000265397.70057.d8"}], "href": "https://doi.org/10.1212/01.wnl.0000265397.70057.d8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17898326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17898326"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "W Y Ng, K F Lui, A C Thai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thyroid (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/105072504773297858"}], "href": "https://doi.org/10.1089/105072504773297858"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15072700"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15072700"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Mohammad-Reza Ghovanloo, Koushik Choudhury, Tagore S Bandaru, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cannabidiol inhibits the skeletal muscle Nav1.4 by blocking its pore and by altering membrane elasticity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gen Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1085/jgp.202012701"}], "href": "https://doi.org/10.1085/jgp.202012701"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33836525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33836525"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Alberto Bergareche, Marcin Bednarz, Elena Sánchez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddv410"}], "href": "https://doi.org/10.1093/hmg/ddv410"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26427606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26427606"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Patrick F Chinnery, Timothy J Walls, Michael G Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Normokalemic periodic paralysis revisited: does it exist?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Neurol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ana.10257"}], "href": "https://doi.org/10.1002/ana.10257"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12210802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12210802"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "E Bugiardini, I Rivolta, A Binda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2015.01.006"}], "href": "https://doi.org/10.1016/j.nmd.2015.01.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25660391"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25660391"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Nathaniel Elia, Johanna Palmio, Marisol Sampedro Castañeda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myasthenic congenital myopathy from recessive mutations at a single residue in Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0000000000007185"}], "href": "https://doi.org/10.1212/WNL.0000000000007185"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30824560"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30824560"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Ging Kuo Wang, Joanna Calderon, Sho-Ya Wang "}, {"type": "b", "children": [{"type": "t", "text": "State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.107.041541"}], "href": "https://doi.org/10.1124/mol.107.041541"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18079277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18079277"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Tomoya Kubota, Masanobu Kinoshita, Ryogen Sasaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New mutation of the Na channel in the severe form of potassium-aggravated myotonia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Muscle Nerve (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mus.21155"}], "href": "https://doi.org/10.1002/mus.21155"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19347921"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19347921"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Rahul R Singh, S Veronica Tan, Michael G Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pediatrics (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1542/peds.2013-3727"}], "href": "https://doi.org/10.1542/peds.2013-3727"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25311598"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25311598"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "M Oana Popa, Alexi K Alekov, Sigrid Bail, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cooperative effect of S4-S5 loops in domains D3 and D4 on fast inactivation of the Na+ channel."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Physiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1113/jphysiol.2004.065912"}], "href": "https://doi.org/10.1113/jphysiol.2004.065912"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15459238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15459238"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Nesrine El-Bizri, Kristopher M Kahlig, John C Shyrock, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Channels (Austin) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/chan.5.2.14851"}], "href": "https://doi.org/10.4161/chan.5.2.14851"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21317558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21317558"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Thomas Carle, Loïc Lhuillier, Sandrine Luce, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2006.07.101"}], "href": "https://doi.org/10.1016/j.bbrc.2006.07.101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16890191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16890191"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Margaret S Dice, Jennifer L Abbruzzese, James T Wheeler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Temperature-sensitive defects in paramyotonia congenita mutants R1448C and T1313M."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Muscle Nerve (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mus.20080"}], "href": "https://doi.org/10.1002/mus.20080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15318338"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15318338"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Véronique Bissay, Sophie C H Van Malderen, Kathelijn Keymolen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Hum Genet (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ejhg.2015.125"}], "href": "https://doi.org/10.1038/ejhg.2015.125"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26036855"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26036855"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "S Petitprez, L Tiab, L Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel dominant mutation of the Nav1.4 alpha-subunit domain I leading to sodium channel myotonia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000335168.86248.55"}], "href": "https://doi.org/10.1212/01.wnl.0000335168.86248.55"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19015483"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19015483"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "James Groome, Frank Lehmann-Horn, Boris Holzherr "}, {"type": "b", "children": [{"type": "t", "text": "Open- and closed-state fast inactivation in sodium channels: differential effects of a site-3 anemone toxin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Channels (Austin) (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4161/chan.5.1.14031"}], "href": "https://doi.org/10.4161/chan.5.1.14031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21099342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21099342"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Alessandro Farinato, Concetta Altamura, Paola Imbrici, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2019.01.004"}], "href": "https://doi.org/10.1016/j.phrs.2019.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30611854"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30611854"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Marianne Arzel-Hézode, Damien Sternberg, Nacira Tabti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Homozygosity for dominant mutations increases severity of muscle channelopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Muscle Nerve (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mus.21520"}], "href": "https://doi.org/10.1002/mus.21520"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19882638"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19882638"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Silvia Corrochano, Roope Männikkö, Peter I Joyce, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/brain/awu292"}], "href": "https://doi.org/10.1093/brain/awu292"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25348630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25348630"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Myeong-Kyu Kim, Seung-Han Lee, Man-Seok Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuromuscul Disord (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nmd.2004.07.005"}], "href": "https://doi.org/10.1016/j.nmd.2004.07.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15482957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15482957"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Chih-Chien Sung, Chih-Jen Cheng, Yi-Fen Lo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype and phenotype analysis of patients with sporadic periodic paralysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Sci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MAJ.0b013e31822b430c"}], "href": "https://doi.org/10.1097/MAJ.0b013e31822b430c"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21841462"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21841462"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "E Rossignol, J Mathieu, I Thiffault, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/01.wnl.0000290831.08585.2c"}], "href": "https://doi.org/10.1212/01.wnl.0000290831.08585.2c"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17998485"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17998485"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Christoph Lossin, Tai-Seung Nam, Shahab Shahangian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0b013e3182684683"}], "href": "https://doi.org/10.1212/WNL.0b013e3182684683"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22914841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22914841"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Carlo Fusco, Daniele Frattini, Grazia Gabriella Salerno, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New phenotype and neonatal onset of sodium channel myotonia in a child with a novel mutation of SCN4A gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Dev (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.braindev.2015.02.004"}], "href": "https://doi.org/10.1016/j.braindev.2015.02.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25735906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25735906"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Johanna Palmio, Satu Sandell, Michael G Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Predominantly myalgic phenotype caused by the c.3466G>A p.A1156T mutation in "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "SCN4A"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurology (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1212/WNL.0000000000003846"}], "href": "https://doi.org/10.1212/WNL.0000000000003846"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28330959"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28330959"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Benedikt G H Schoser, J Michael Schröder, Timo Grimm, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A large German kindred with cold-aggravated myotonia and a heterozygous A1481D mutation in the SCN4A gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Muscle Nerve (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mus.20733"}], "href": "https://doi.org/10.1002/mus.20733"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17212350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17212350"}]}, {"type": "r", "ref": 47, "children": [{"type": "t", "text": "Hugo Poulin, Pascal Gosselin-Badaroudine, Savine Vicart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Substitutions of the S4DIV R2 residue (R1451) in Na"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "V"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": "1.4 lead to complex forms of paramyotonia congenita and periodic paralyses."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-20468-0"}], "href": "https://doi.org/10.1038/s41598-018-20468-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29391559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29391559"}]}, {"type": "r", "ref": 48, "children": [{"type": "t", "text": "Silvia Corrochano, Gonzalo Blanco, Debbie Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genetic modifier suggests that endurance exercise exacerbates Huntington's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddy077"}], "href": "https://doi.org/10.1093/hmg/ddy077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29509900"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29509900"}]}, {"type": "r", "ref": 49, "children": [{"type": "t", "text": "Isabelle J McCollum, Yuriy Y Vilin, Elizabeth Spackman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Negatively charged residues adjacent to IFM motif in the DIII-DIV linker of hNa(V)1.4 differentially affect slow inactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0014-5793(03)00912-8"}], "href": "https://doi.org/10.1016/s0014-5793(03"}, {"type": "t", "text": "00912-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14527681"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14527681"}]}]}]}
Synonyms NAV1.4, HOKPP2, NAC1A, NA(V)1.4, SKM1, CMS16, HYKPP, HYPP
Proteins SCN4A_HUMAN
NCBI Gene ID 6329
API
Download Associations
Predicted Functions View SCN4A's ARCHS4 Predicted Functions.
Co-expressed Genes View SCN4A's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View SCN4A's ARCHS4 Predicted Functions.

Functional Associations

SCN4A has 5,486 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 119 datasets.

Click the + buttons to view associations for SCN4A from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN4A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN4A gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of SCN4A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of SCN4A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SCN4A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of SCN4A gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of SCN4A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN4A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of SCN4A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN4A gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of SCN4A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of SCN4A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations phenotypes associated with SCN4A gene from the curated ClinVar Gene-Phenotype Associations dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with SCN4A gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SCN4A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing SCN4A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing SCN4A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing SCN4A protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with SCN4A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with SCN4A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN4A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with SCN4A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with SCN4A gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with SCN4A gene/protein from the curated CTD Gene-Disease Associations dataset.
dbGAP Gene-Trait Associations traits associated with SCN4A gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by SCN4A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving SCN4A gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving SCN4A gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with SCN4A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with SCN4A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with SCN4A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with SCN4A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for SCN4A protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SCN4A gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of SCN4A gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of SCN4A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing SCN4A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with SCN4A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with SCN4A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of SCN4A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with SCN4A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing SCN4A from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of SCN4A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GlyGen Glycosylated Proteins ligands (chemical) binding SCN4A protein from the GlyGen Glycosylated Proteins dataset.
GO Biological Process Annotations 2015 biological processes involving SCN4A gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving SCN4A gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving SCN4A gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing SCN4A protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing SCN4A protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing SCN4A protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by SCN4A gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by SCN4A gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by SCN4A gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of SCN4A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of SCN4A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding SCN4A receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with SCN4A gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with SCN4A gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with SCN4A gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of SCN4A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for SCN4A protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of SCN4A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of SCN4A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of SCN4A protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with SCN4A gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for SCN4A from the curated Hub Proteins Protein-Protein Interactions dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with SCN4A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by SCN4A gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for SCN4A protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of SCN4A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of SCN4A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of SCN4A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate SCN4A protein from the curated KEA Substrates of Kinases dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of SCN4A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with SCN4A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of SCN4A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of SCN4A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LOCATE Curated Protein Localization Annotations cellular components containing SCN4A protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain SCN4A protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by SCN4A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting SCN4A gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of SCN4A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by SCN4A gene mutations from the MPO Gene-Phenotype Associations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of SCN4A gene from the NIBR DRUG-seq U2OS MoA Box dataset.
OMIM Gene-Disease Associations phenotypes associated with SCN4A gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for SCN4A from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of SCN4A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of SCN4A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving SCN4A protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving SCN4A protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with SCN4A protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
Reactome Pathways 2014 pathways involving SCN4A protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving SCN4A protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of SCN4A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at SCN4A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of SCN4A gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of SCN4A gene from the RummaGEO Gene Perturbation Signatures dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of SCN4A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of SCN4A gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of SCN4A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of SCN4A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of SCN4A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SCN4A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of SCN4A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of SCN4A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with SCN4A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with SCN4A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2024 pathways involving SCN4A protein from the WikiPathways Pathways 2024 dataset.